Jacobs Levy Equity Management’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
SCM
QF
Jacobs Levy Equity Management's ATEX Position: Q3 2024 in Review
Jacobs Levy Equity Management sold out of Anterix (ATEX) in Q3 2024, closing a stake of 8,500 shares — an estimated $337K sold.
Jacobs Levy Equity Management first reported a position in ATEX in Q1 2022 and held it in 2 quarters. The position peaked at $337K in Q2 2024. 129 funds tracked by Wall St. Rank hold ATEX as of Q3 2024.
- Jacobs Levy Equity Management reported no remaining Anterix position as of Q3 2024 after selling out during the quarter.
- Jacobs Levy Equity Management sold 8,500 Anterix shares in Q3 2024, an estimated $337K.
- Jacobs Levy Equity Management first reported a position in Anterix in Q1 2022 and held it in 2 quarters.
- Jacobs Levy Equity Management's Anterix position peaked at $337K in Q2 2024.
- 129 funds tracked by Wall St. Rank held Anterix as of Q3 2024.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.